Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer.
Teele KuuskDavid CullenJoana Briosa NevesNicholas CampainRavi BarodEkaterini BoletiSoha El-SheihkLee GrantJohn KellyMarta MarchettiFaiz MumtazPrasad PatkiNavin RamachandranPedro SilvaMy-Anh Tran-DangMiles WalkdenMaxine G B TranThomas PowlesAxel BexPublished in: BJU international (2021)
The first surge of the COVID-19 pandemic severely impacted diagnosis, referral and treatment of kidney cancer at a tertiary referral centre. With a policy of prioritization and COVID-protected pathways, capacity for time-sensitive oncological interventions was maintained and no immediate clinical harm was observed.